Reversion and antihistamines.
Gupta
S K
SK
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000517:prevention & control*; D001507:Beclomethasone / Q000627:therapeutic use; D017332:Cetirizine / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D014663:Nasal Decongestants / Q000627:therapeutic use; D012008:Recurrence; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D016593:Terfenadine / Q000627:therapeutic use
D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D016593:Terfenadine; D001507:Beclomethasone; D004205:Cromolyn Sodium; D017332:Cetirizine